Le Lézard
Classified in: Health
Subject: SVY

The pulmonary embolism therapeutics market will register a CAGR of 9% by 2023


NEW YORK, May 22, 2019 /PRNewswire/ --

About this market

The increasing awareness programs and campaigns are expected to trigger the pulmonary embolism therapeutics market growth during the forecast period. The increasing awareness campaigns will improve the awareness of the severity of blood clots, resulting in various patients undergoing diagnosis and treatment on time. Such growing popularity will eventually boost the market growth in the forthcoming years. Analysts have predicted that the pulmonary embolism therapeutics market will register a CAGR of 9% by 2023.



Read the full report: https://www.reportlinker.com/p05777274/?utm_source=PRN



Market Overview

Increasing oral anticoagulants

Traditionally, the global pulmonary embolism therapeutics market was dominated by Heparin, an anticoagulant drug, which is administered through parenteral route. The market also had various other anticoagulant drugs that were approved; however, most of these drugs were administered through invasive routes. These drugs require no or very less patient monitoring unlike their predecessors from the parenteral route. This will further aid to the popularity of oral anticoagulants.

Preference for alternative therapies

The increasing popularity and the advances in alternative treatment methods are expected to pose a major challenge to the growth of the global pulmonary embolism therapeutics market during the forecast period.

For the detailed list of factors that will drive and challenge the growth of the pulmonary embolism therapeutics market during 2019-2023, view our report.

Competitive Landscape

The market appears to be highly concentrated and with the presence of a few market players. Several vendors in the market are also entering into strategic alliances to manufacture the drugs so that they could concentrate on their core competencies such as research. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market's competitive landscape and offering information on the products offered by companies.

Read the full report: https://www.reportlinker.com/p05777274/?utm_source=PRN

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker


These press releases may also interest you

at 02:20
BioInvent International (STO:BINV)"During the first quarter of the year, we continued making excellent progress with our clinical pipeline targeting TNFR2 and FcyRIIB, building on the momentum we generated during a very successful 2023. Looking...

at 01:00
PARIS, FRANCE, 24 April 2024 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-care biopharmaceutical company, today presents its sales for the first quarter of 2024. ? ?  Q1 2024? Q1 2023? % change? ?m? ?m? ActualCER1Growth...

23 avr 2024
GenScript, a global leader in life sciences and biotechnology, successfully hosted an Open Day event at its Singapore facility on the 16th of April, welcoming more than 50 representatives from Singapore. This event provided an exclusive look into...

23 avr 2024
Cybervation, an award-winning global technology and healthcare solutions company, proudly announces that its CEO, Purba Majumder, has been distinguished as one of the 2024 100 Women to KNOW Across America. This award from KNOW Women recognizes...

23 avr 2024
The report titled "Glycated Albumin Assay Market by Product (Animal Glycated Albumin Assay, Human Glycated Albumin Assay), Application (Prediabetes, Type 1 Diabetes, Type 2 Diabetes), End User - Global Forecast 2024-2030" is now available on...

23 avr 2024
The report titled "Health & Wellness Food Market by Type (Fresh & Natural, Functional Foods & Beverages, Heat & Eat), Nature (Genetically Modified Organism Food, Non-Genetically Modified Organism Food), Fat Content, Category, Free From Category,...



News published on and distributed by: